Syndax Pharmaceuticals
Price & Volume
Stats
See more52W Range | $11.62-$25.07 |
Market Cap | $1B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $23.6M |
Revenue Growth (YoY) | 33,297.4% |
Gross Profit (12 Mos) | -$218.7M |
Diluted EPS | -$3.72 |
News
See moreYahoo Finance • last month
Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
Syndax Announces Participation in March Investor Conferences
Yahoo Finance • last month
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025
Yahoo Finance • 2 months ago
Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
About
CEO | Mr. Michael A. Metzger M.B.A. |
CFO | Mr. Keith Alan Goldan CPA |
Address | 730 Third Avenue, New York, NY, United States, 10017 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
